Nyxoah's Major Milestone: Launch of the Genio System
Nyxoah, a dynamic medical technology company, has achieved a significant breakthrough with the launch of its Genio system, now available in the Netherlands. This innovative treatment option aims to provide better solutions for individuals suffering from Obstructive Sleep Apnea (OSA), a condition that affects millions worldwide.
First Successful Implants
The commercial rollout of the Genio system features its first successful implants performed at prestigious hospitals, highlighting the effectiveness and reliability of this cutting-edge therapy. The OLVG West in Amsterdam and Zuyderland Hospital in Heerlen have taken the initiative to introduce this state-of-the-art solution, providing patients with an alternative to Continuous Positive Airway Pressure (CPAP) therapy.
Expert Insights on Genio
Dr. Peter van Maanen, an ENT surgeon at OLVG West, shared his enthusiasm about the Genio system, stating that it presents a much-needed additional treatment option for patients who find CPAP intolerable. With its unique features, including stimulation of both branches of the nerve and compatibility with different MRI settings, Genio represents a promising long-term solution for OSA patients.
Expanding Patient Care at Zuyderland Hospital
At Zuyderland Hospital, Dr. Jos Straetmans echoed similar sentiments regarding the Genio system. The ability to tailor therapies to meet individual patient needs is crucial in healthcare, and the no-battery installation ensures reliable performance, especially in the supine position. This innovative solution not only enhances patient care but also expands the hospital’s treatment arsenal.
Nyxoah’s Vision for the Future
Olivier Taelman, the CEO of Nyxoah, expressed pride in the company’s efforts to partner with leading healthcare institutions in the Netherlands. The introduction of the Genio system is a major step in Nyxoah's European strategy, aimed at providing patients with effective alternatives to traditional therapy methods. The company is committed to establishing its presence and solidifying its role in the OSA treatment category.
The Genio System: A Breakthrough Solution
Nyxoah's Genio system has been developed as a groundbreaking, patient-centric alternative for those struggling with OSA. Unlike conventional therapies, Genio’s leadless and battery-free hypoglossal neurostimulation offers a modern approach to managing this prevalent health condition. This initiative stems from the company's dedication to improving the quality of life for OSA patients by assuring they enjoy restful sleep.
Proven Results and Expansion
Since obtaining its European CE Mark certification in 2019, the Genio system has undergone extensive testing, resulting in validated efficacy and safety. Recent positive outcomes from clinical studies further support Nyxoah’s mission to provide unparalleled treatment options for OSA, including those with Complete Concentric Collapse (CCC).
Regulatory Milestones
Additionally, with the FDA’s recent approval of Genio for a subset of adult patients suffering from moderate to severe OSA, Nyxoah is positioned to broaden its market reach and fulfill its vision of delivering effective therapies to patients on a global scale.
Frequently Asked Questions
What is the Genio system?
The Genio system is a leadless, battery-free neurostimulation therapy designed to treat Obstructive Sleep Apnea (OSA), offering patients a new option beyond CPAP.
Where has the Genio system been launched?
The Genio system has recently been launched in the Netherlands, with initial successful implants performed at OLVG West and Zuyderland Hospital.
What are the benefits of using the Genio system?
Key benefits of the Genio system include its ability to stimulate both branches of the nerve and its compatibility with various MRI conditions, providing patients with a reliable and adaptable treatment option.
Is the Genio system FDA approved?
Yes, the Genio system received FDA approval for specific adult patients with moderate to severe OSA, further validating its efficacy and safety.
How does Nyxoah support OSA patients?
Nyxoah is dedicated to improving patient care through innovative solutions like the Genio system, aiming to ensure that individuals with OSA can enjoy restful sleep and improve their overall quality of life.
